IRMD
Iradimed CorpCompany with tickers: IRMD
CIK
1325618
CUSIP
46266A109
Shares Outstanding
12,783,035
Website
https://www.iradimed.com
13F Activity (30d)
99 filings
95 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| United States | $52,525,449 | $60,607,000 | $70,558,000 |
| Non Us | — | $12,635,000 | $13,256,000 |
| International | $13,036,847 | $12,635,237 | — |